NCT04628325View on ClinicalTrials.gov

Effects of Furosemide Plus Small HSS in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF)

PHASE3CompletedINTERVENTIONAL
Enrollment

136

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

June 30, 2019

Study Completion Date

May 1, 2020

Conditions
Heart Failure，Congestive
Interventions
DRUG

Furosemide

Intravenous Furosemide Plus Small Hypertonic Saline Solutions (HSS)

Trial Locations (2)

90127

AOUP Paolo Giaccone, Palermo

Internal Medicine Ward of Palermo University Hospital, Palermo

All Listed Sponsors
lead

University of Palermo

OTHER

NCT04628325 - Effects of Furosemide Plus Small HSS in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF) | Biotech Hunter | Biotech Hunter